Nutritional deficiency and nutritional therapy in cancer patients. Overview of current recommendations
Keywords:nutritional deficiency, nutrition, cancer, overview
Nutritional deficiency is a common complication in the course of cancer. According to the European Society for Clinical Nutrition and Metabolism (2017), the incidence of nutritional deficiency in cancer patients ranged from 47 to 89 %. Nutritional deficiency can reach terminal manifestations and proceed in the form of anorexia-cachexia syndrome, being the direct cause of death in 4 out of 20 cancer patients. The prognosis for cancer patients with weight loss is worse than for patients without weight loss. Although the stage of the tumor and resistance to anticancer therapy are the main prognostic factors for patient survival, a large amount of literature data shows that weight loss is a significant and often independent predictor of reduced survival in cancer patients. The review addresses the issues of improving the nutritional status of cancer patients and the main approaches to the treatment of this complication.
Arends J., Baracos V., Bertz H., Bozzetti. F. ESPEN expert group recommendations for action against cancerrelated malnutrition. Clinical Nutrition. 2017. 36. 1187-1196.
DeWys W.D., Begg C., Lavin P.T. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am. J. Med. 1980. 69. 491-497.
Bozzetti F., Arends J., Lundholm K. ESPEN Guidelines on Parenteral Nutrition: Non-surgical oncology. Clinical Nutrition. 2009. 28. 445-454.
Bozzetti F., Migliavacca S., Scotti A. Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann. Surg. 1982. 196(2). 170-179.
Van Bokorst-de van der Schueren M.A.E., van Leeuwen P.A.M., Kuik D.J. The impact of nutritional status on the prognosis of patients with advanced head and neck cancer. Cancer. 1999. 86. 519-527.
Bosaeus I., Daneryd P., Lundholm K. Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J. Nutr. 2002. 132(suppl. 11). 3465S-6S.
Kadar L., Albertson M., Areberg J. The prognostic value of body protein in patients with lung cancer. Ann. NY Acad. Sci. 2000. 904. 584-591.
Van Eys J. Effect of nutritional status on response to therapy. Cancer. Res. 1982. 1982. 42(suppl.). 747-753.
Inagaki J., Rodriguez V., Bodey G.P. Proceedings: Causes of death in cancer patients. Cancer. 1974. 33(2). 568-573.
Arends J., Bachmann P., Baracos V. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition. 2017. 36(1).
Dechaphunkul T., Martin L., Alberda C. Crit. Rev. Oncol. Hematol. 2013. 88. 459-476.
Arends J., Bodoky G., Bozzetti F. DGEM (German Society for Nutritional Medicine), ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin. Nutr. 2006. 25.
Arends J., Bodoky G., Bozzetti F., Fearon K. DGEM (German Society for Nutritional Medicine), ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin. Nutr. 2009. 28. 445-454.
Martin L., Senesse P., Gioulbasanis I. Diagnostic criteria for the classification of cancer-associated weight loss. J. Clin. Oncol. 2015. 33. 90-99.
McMillan D.C. The systemic inflammation-based glasgow prognostic score: a decade of experience in patients with cancer. Cancer. Treat. Rev. 2013. 39. 534-540.
Pan H., Cai S., Ji J. The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center, prospective cohort study in Chinese teaching hospitals. Nutr. Cancer. 2013. 65. 62-70.
Isenring E., Elia M. Which screening method is appropriate for older cancer patients at risk for malnutrition? Nutrition. 2015. 31. 594-597.
Ravasco P., Monteiro-Grillo I., Vidal P.M. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J. Clin. Oncol. 2005. 23. 1431-1438.
Ravasco P., Monteiro-Grillo I., Marques Vidal P. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005. 27. 659-668.
Baracos V.E. Skeletal muscle anabolism in patients with advanced cancer. Lancet Oncol. 2015. 16. 13-24.
Nitenberg G., Raynard B. Nutritional Support of the cancer patient: issues and dilemmas. Crit. Rev. Oncol. Hematol. 2000. 34. 137-168.
Barrera R. Nutritional support in cancer patients. J. Parent. Enter. Nutr. 2002. 26(suppl. 5). 563-571.
Baracos V.E. Meeting the aminoacid requirements for protein anabolism in cancer cachexia. In: Mantovani G., ed. Cachexia and wasting. A modern approach. Springer Milan. 2006.
Guadagni M., Biolo G. Effects of inflammation and/or inactivity on the need for dietary protein. Curr. Opin. Clin. Nutr. Metab. Care. 2009. 12. 617-622.
Haran P.H., Rivas D.A. Role and potential mechanisms of anabolic resistance in sarcopenia. J. Cachexia Sarcopenia Muscle. 2012. 3. 157-162.
Deutz N.E., Bauer J.M., Barazzoni R., Biolo G. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr. 2014. 33. 929-936.
MacDonald A.J., Johns N., Stephens N.A., Greig C. Habitual myofibrillar protein synthesis is normal in patients with upper GI cancer cachexia. Clin. Cancer. Res. 2015. 21.
Bozzetti F., Bozzetti V. Is the intravenous administration of amino acid adequate in cancer patients? A critical appraisal of literature. Clin. Nutr. 2013. 32. 142-146.
Winter A., Macadams J., Chevalier S. Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia. Clin. Nutr. 2005. 31.
Martin W.F., Armstrong L.E., Rodriguez N.R. Dietary protein intake and renal function. Nutr. Metab. Lond. 2005. 20. 2-25.
Cano N., Fiaccadori E., Tesinsky P., Toigo G. DGEM (German Society for Nutritional Medicine). ESPEN guidelines on enteral nutrition: adult renal failure. Clin. Nutr. 2006. 25.
Tayek J.A., Bistrian B.R., Hehir D.J. Improved protein kinetics and albumin synthesis by branched chain aminoacid-enriched total parenteral nutrition in cancer cachexia. A prospective randomized crossover trial. Cancer. 1986. 58. 147-157.
Hunter D.C., Weintraub M., Blackburn G.L. Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia. Br. J. Surg. 1989. 76. 149-53.
Deutz N.E., Safar A., Schutzler S., Memelink R. Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. Clin. Nutr. 2011. 30. 759-768.
Muscaritoli M., Anker S.D., Argiles J. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics. Clin. Nutr. 2010. 29. 154-159.
Bozzetti F. Nutritional support in patients with oesophageal cancer. Support Care Cancer. 2010. 18(suppl. 2). S41-50.
Bourdel-Marchasson I., Blanc-Bisson C., Doussau A. Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One. 2014. 9. e108687.
Nugent B., Parker M.J., McIntyre I.A. Nasogastric tube feeding and percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer. J. Hum. Nutr. Diet. 2010. 23. 277-284.
Bozzetti F., Santarpia L., Pironi L., Thul P. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann. Oncol. 2014. 25. 487-493.
Bozzetti F. Nutritional support in patients with oesophageal cancer. Support Care Cancer. 2010. 18(suppl. 2). S51-53.
Faber J., Berkhout M., Fiedler U., Avlar M. Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial. Clin. Nutr. 2013. 32. 338-345.
Silva J., Trindade E.B., Fabre M.E., Menegotto V.M. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr. Cancer. 2012. 64.
Mocellin M.C., Camargo C.Q., Nunes E.A., Fiates G.M. A systematic review and meta-analysis of the N-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer. Clin. Nutr. 2016. 35. 359-369.
Colomer R., Moreno-Nogueira J.M., García-Luna P.P., García-Peris P. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br. J. Nutr. 2007. 97. 823-831.
De Aguiar Pastore Silva J., Emilia de Souza Fabre M., Waitzberg D.L. Omega-3 supplements for patients in chemotherapy and/or radiotherapy: a systematic review. Clin. Nutr. 2015. 34. 359-366.
Murphy R.A., Mourtzakis M., Chu Q.S., Baracos V.E. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer. 2011. 117. 3774-3780.
Bougnoux P., Hajjaji N., Ferrasson M.N., Giraudeau B. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br. J. Cancer. 2009. 101. 1978-1985.
Michael-Titus A.T., Priestley J.V. Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity? Trends Neurosci. 2014. 37. 30-38.
Sanchez-Lara K., Turcott J.G., Juarez-Hernandez E., Nunez-Valencia C. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin. Nutr. 2014. 33. 1017-1123.
Hubbard G.P., Buchan B., Sanders K., Brothers S. Improved compliance and increased intake of energy and protein with a high energy density, low volume multi-nutrient supplement. Proceedings of the Nutrition Society. 2010. 69. OCE2. E164.
Lorefalt B., Wissng U., Unosson M. Smaller but energy and protein-enriched meals improve energy and nutrient intakes in elderly patients. J. Nutrition, Health & Aging. 2005. 9. 243-247.
Copyright (c) 2020 Practical oncology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.